Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2016 Filed Nov 17, 2016 01:01 UTC |
CAHILL EDWARD LDirector
|
GrantStock Options · Derivative | 17,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001209191-16-150721 · doc4.xml · derivative · entry 1 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 01:05 UTC |
TWOMEY CHRISTOPHER JDirector
|
GrantStock Options · Derivative | 17,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001209191-16-150725 · doc4.xml · derivative · entry 1 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 01:04 UTC |
ROEDER DOUGLAS ADirector · 10% owner
|
GrantStock Options · Derivative | 17,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001209191-16-150724 · doc4.xml · derivative · entry 1 ROEDER DOUGLAS A · CIK 0001270735 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 01:00 UTC |
Allen DickDirector
|
GrantStock Options · Derivative | 17,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001209191-16-150720 · doc4.xml · derivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 01:02 UTC |
Cohen Fred EDirector
|
GrantStock Options · Derivative | 17,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001209191-16-150722 · doc4.xml · derivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 00:56 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
GrantCommon Stock | 3,671 | $1.62 | $5,947.02 |
DisclosureSEC source: 0001209191-16-150719 · doc4.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,671 F1 · date: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 16, 2016 through November 15, 2016. This transaction is also exempt under Rule 16b-3(c). F2 · date: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on November 15, 2016. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 16:18 UTC |
TREU JESSE IDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0000904454-16-001576 · edgar.xml · derivative · entry 1 TREU JESSE I · CIK 0001013425 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2026-11-15 F1 · derivative.exercise_date: The option vests in 12 equal monthly installments beginning on 12/15/2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.